ArticleCancers2024

Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience.

Jérémy Baude et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.